lvlup bpc-157 BPC-157 — Pacific Peptide Sciences
Description
La dose abituale compresa tra 200 e 500 mcg di BPC 157 per iniezione, una volta al giorno
Structural Stability: The disulfide bond between Cysteine 7 and Cysteine 14 creates a rigid cyclic loop essential for receptor recognition
Furthermore, the question whether Vit B12 should be considered as symptomatic treatment in PD or as a disease modifying therapy remains triggering and unresolved
Honesty about evidence up front: there is no registered human clinical trial of the KLOW blend itself
